Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19843034rdf:typepubmed:Citationlld:pubmed
pubmed-article:19843034lifeskim:mentionsumls-concept:C0376387lld:lifeskim
pubmed-article:19843034lifeskim:mentionsumls-concept:C0018787lld:lifeskim
pubmed-article:19843034lifeskim:mentionsumls-concept:C0450127lld:lifeskim
pubmed-article:19843034lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:19843034lifeskim:mentionsumls-concept:C0917874lld:lifeskim
pubmed-article:19843034lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:19843034pubmed:issue11lld:pubmed
pubmed-article:19843034pubmed:dateCreated2009-10-21lld:pubmed
pubmed-article:19843034pubmed:abstractTextThe aim of our study was to investigate the ability of Strain-Encoded magnetic resonance imaging (MRI) to detect cardiac allograft vasculopathy (CAV) in heart transplantation (HTx)-recipients. In consecutive subjects (n = 69), who underwent cardiac catheterization, MRI was performed for quantification of myocardial strain and perfusion reserve. Based on angiographic findings subjects were classified: group A including patients with normal vessels; group B, patients with stenosis <50%; and group C, patients with severe CAV (stenosis >or= 50%). Significant correlations were observed between myocardial perfusion reserve with peak systolic strain (r =-0.53, p < 0.001) and with mean diastolic strain rate (r = 0.82, p < 0.001). Peak systolic strain and strain rate were significantly reduced only in group C, while mean diastolic strain rate and myocardial perfusion reserve were already reduced in group B and A. Myocardial perfusion reserve and mean diastolic strain rate had higher accuracy for the detection of CAV (AUC = 0.95, 95% CI = 0.87-0.99 and AUC = 0.93, 95% CI = 0.84-0.98, respectively) and followed peak systolic strain and strain rate (AUC = 0.80, 95% CI = 0.69-0.89 and AUC = 0.78, 95% CI = 0.67-0.87, respectively). Besides the quantification of myocardial perfusion, the estimation of the diastolic strain rate is a useful parameter for CAV assessment. In combination with the clinical evaluation, these parameters may be effective tools for the routine surveillance of HTx-recipients.lld:pubmed
pubmed-article:19843034pubmed:languageenglld:pubmed
pubmed-article:19843034pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19843034pubmed:citationSubsetIMlld:pubmed
pubmed-article:19843034pubmed:statusMEDLINElld:pubmed
pubmed-article:19843034pubmed:monthNovlld:pubmed
pubmed-article:19843034pubmed:issn1600-6143lld:pubmed
pubmed-article:19843034pubmed:authorpubmed-author:SteenHHlld:pubmed
pubmed-article:19843034pubmed:authorpubmed-author:DenglerT JTJlld:pubmed
pubmed-article:19843034pubmed:authorpubmed-author:KatusH AHAlld:pubmed
pubmed-article:19843034pubmed:authorpubmed-author:GiannitsisEElld:pubmed
pubmed-article:19843034pubmed:authorpubmed-author:OsmanN FNFlld:pubmed
pubmed-article:19843034pubmed:authorpubmed-author:LehrkeSSlld:pubmed
pubmed-article:19843034pubmed:authorpubmed-author:KorosoglouGGlld:pubmed
pubmed-article:19843034pubmed:authorpubmed-author:RiedleNNlld:pubmed
pubmed-article:19843034pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19843034pubmed:volume9lld:pubmed
pubmed-article:19843034pubmed:ownerNLMlld:pubmed
pubmed-article:19843034pubmed:authorsCompleteYlld:pubmed
pubmed-article:19843034pubmed:pagination2587-96lld:pubmed
pubmed-article:19843034pubmed:meshHeadingpubmed-meshheading:19843034...lld:pubmed
pubmed-article:19843034pubmed:meshHeadingpubmed-meshheading:19843034...lld:pubmed
pubmed-article:19843034pubmed:meshHeadingpubmed-meshheading:19843034...lld:pubmed
pubmed-article:19843034pubmed:meshHeadingpubmed-meshheading:19843034...lld:pubmed
pubmed-article:19843034pubmed:meshHeadingpubmed-meshheading:19843034...lld:pubmed
pubmed-article:19843034pubmed:meshHeadingpubmed-meshheading:19843034...lld:pubmed
pubmed-article:19843034pubmed:meshHeadingpubmed-meshheading:19843034...lld:pubmed
pubmed-article:19843034pubmed:meshHeadingpubmed-meshheading:19843034...lld:pubmed
pubmed-article:19843034pubmed:meshHeadingpubmed-meshheading:19843034...lld:pubmed
pubmed-article:19843034pubmed:meshHeadingpubmed-meshheading:19843034...lld:pubmed
pubmed-article:19843034pubmed:meshHeadingpubmed-meshheading:19843034...lld:pubmed
pubmed-article:19843034pubmed:meshHeadingpubmed-meshheading:19843034...lld:pubmed
pubmed-article:19843034pubmed:meshHeadingpubmed-meshheading:19843034...lld:pubmed
pubmed-article:19843034pubmed:meshHeadingpubmed-meshheading:19843034...lld:pubmed
pubmed-article:19843034pubmed:meshHeadingpubmed-meshheading:19843034...lld:pubmed
pubmed-article:19843034pubmed:meshHeadingpubmed-meshheading:19843034...lld:pubmed
pubmed-article:19843034pubmed:meshHeadingpubmed-meshheading:19843034...lld:pubmed
pubmed-article:19843034pubmed:meshHeadingpubmed-meshheading:19843034...lld:pubmed
pubmed-article:19843034pubmed:meshHeadingpubmed-meshheading:19843034...lld:pubmed
pubmed-article:19843034pubmed:year2009lld:pubmed
pubmed-article:19843034pubmed:articleTitleStrain-encoded cardiac magnetic resonance for the evaluation of chronic allograft vasculopathy in transplant recipients.lld:pubmed
pubmed-article:19843034pubmed:affiliationDepartment of Cardiology, University of Heidelberg, Heidelberg, Germany. gkorosoglou@hotmail.comlld:pubmed
pubmed-article:19843034pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19843034pubmed:publicationTypeControlled Clinical Triallld:pubmed